119 related articles for article (PubMed ID: 26152287)
21. [Expression of SALL4 gene in patients with acute and chronic myeloid leukemia].
Chen Q; Qian J; Lin J; Yang J; Li Y; Wang CZ; Chai HY; Chen XX; Qian Z; Ma JC; Zhang M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):315-9. PubMed ID: 23628023
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of miR-24 is associated with acute myeloid leukemia with t(8;21).
Yin JY; Tang Q; Qian W; Qian J; Lin J; Wen XM; Zhou JD; Zhang YY; Zhu XW; Deng ZQ
Int J Clin Exp Pathol; 2014; 7(11):8032-8. PubMed ID: 25550847
[TBL] [Abstract][Full Text] [Related]
23. Let-7a-3 hypomethylation is associated with favorable/intermediate karyotypes but not with survival in acute myeloid leukemia.
Zhu XW; Yao DM; Wu DH; Wen XM; Yang J; Guo H; Yang L; Deng ZQ; Zhang YY; Qian W; Lin J; Qian J
Tumour Biol; 2016 Jan; 37(1):491-501. PubMed ID: 26227220
[TBL] [Abstract][Full Text] [Related]
24. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
25. Oct4 expression in gastric carcinoma: association with tumor proliferation, angiogenesis and survival.
El-Guindy DM; Wasfy RE; Abdel Ghafar MT; Ali DA; Elkady AM
J Egypt Natl Canc Inst; 2019 Nov; 31(1):3. PubMed ID: 32372156
[TBL] [Abstract][Full Text] [Related]
26. SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia.
Deng A; Ning Q; Zhou L; Liang Y
Sci Rep; 2016 Jun; 6():27694. PubMed ID: 27291931
[TBL] [Abstract][Full Text] [Related]
27. Reduced expression of chemerin is associated with poor clinical outcome in acute myeloid leukemia.
Zhang J; Zhou J; Tang X; Zhou LY; Zhai LL; Vanessa ME; Yi J; Yi YY; Lin J; Qian J; Deng ZQ
Oncotarget; 2017 Nov; 8(54):92536-92544. PubMed ID: 29190935
[TBL] [Abstract][Full Text] [Related]
28. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
[TBL] [Abstract][Full Text] [Related]
29. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
30. Prognostic role of TPD52 in acute myeloid leukemia: A retrospective multicohort analysis.
Ha M; Han ME; Kim JY; Jeong DC; Oh SO; Kim YH
J Cell Biochem; 2019 Mar; 120(3):3672-3678. PubMed ID: 30203488
[TBL] [Abstract][Full Text] [Related]
31. TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemia.
Wang N; Guo D; Zhao YY; Dong CY; Liu XY; Yang BX; Wang SW; Wang L; Liu QG; Ren Q; Lin YM; Ma XT
Oncotarget; 2015 Aug; 6(25):20977-92. PubMed ID: 26023795
[TBL] [Abstract][Full Text] [Related]
32. Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia.
Fu L; Shi J; Hu K; Wang J; Wang W; Ke X
Oncotarget; 2015 Apr; 6(10):8144-54. PubMed ID: 25924238
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia.
Qian J; Lin J; Qian W; Ma JC; Qian SX; Li Y; Yang J; Li JY; Wang CZ; Chai HY; Chen XX; Deng ZQ
Leuk Res; 2013 Jul; 37(7):765-8. PubMed ID: 23582927
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
36. Clinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemia.
Chen YK; Hou HA; Tang JL; Jhuang JY; Lai YJ; Lee MC; Kuo YY; Chou WC; Liu CY; Lin CW; Chuang SS; Chen CY; Tseng MH; Huang CF; Chiang YC; Lee FY; Liu MC; Liu CW; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
PLoS One; 2015; 10(3):e0119831. PubMed ID: 25794001
[TBL] [Abstract][Full Text] [Related]
37. Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia.
Zhi Y; Xie X; Wang R; Wang B; Gu W; Ling Y; Dong W; Zhi F; Liu Y
Int J Hematol; 2015 Sep; 102(3):296-303. PubMed ID: 26134365
[TBL] [Abstract][Full Text] [Related]
38. DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.
Zhou JD; Zhang TJ; Wang YX; Yang DQ; Yang L; Ma JC; Wen XM; Yang J; Lin J; Qian J
Tumour Biol; 2016 Jul; 37(7):8951-60. PubMed ID: 26753961
[TBL] [Abstract][Full Text] [Related]
39. HOTAIR is upregulated in acute myeloid leukemia and that indicates a poor prognosis.
Hao S; Shao Z
Int J Clin Exp Pathol; 2015; 8(6):7223-8. PubMed ID: 26261618
[TBL] [Abstract][Full Text] [Related]
40. Cyclin D1 expression in acute leukemia.
Aref S; Mabed M; El-Sherbiny M; Selim T; Metwaly A
Hematology; 2006 Feb; 11(1):31-4. PubMed ID: 16522546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]